TrialAmerican journal of respiratory and critical care medicine2019

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial.

Dirk-Jan Slebos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.